Trial intelligence / Profile preview

Insulin glargine versus insulin detemir added to metformin in type 2 diabetes

2007-006109-26Phase 4Completed

Sponsor
IKFE
Start
Nov 2007
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of insulin glargine, insulin detemir and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by IKFE. Primary endpoint: Postprandial intact proinsulin secretion. Started Nov 2007; status: completed.

02

Drugs

insulin glargineinsulin detemirmetformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2007-006109-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006109-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call